Much attention has been given to Cannabidiol (CBD) over the past two years due to the anti-epileptic but non-psychoactive properties demonstrated on Dr Sanjay Gupta’s CNN specials “Weed” and “Weed 2: Cannabis Madness.” The inspiring story of Charlotte Figi, an epileptic infant girl who was able to significantly reduce her grand mal seizures by taking CBD medicine, has led doctors and scientists throughout the world to further studying and learning about this powerful therapeutic compound.

Not only does CBD possess anti-epileptic properties that can be used to treat both Epilepsy and Parkinson’s Disease seizures and tremors, but this non-psychoactive cannabinoid (it won’t get you high) possesses a slew of medically valuable properties which include: analgesia, anti-anxiety, anti-bacterial, anti-cancer, anti-convulsant, anti-depressant, anti-emetic, anti-inflammatory, anti-insomnia, anti-ischemic, anti-psychotic, anti-spasmotic, bone stimulating, immunosuppressive, and neuroprotective.

With all the buzz and attention surrounding this exciting compound, it would be exciting to share the history of CBD, and the paper “Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action” by Antonio Zuardi published in 2008 is a peer reviewed scientific paper which covers exactly that. Several topics are discussed in this exhaustive review, from the discovery of the cannabidiol chemical structure in 1963, to several of the worldwide studies in the 70s that looked at the anti-epileptic and sedative effects of both THC and CBD, all the way to studies in the 80s, 90s, and over the past decade that further looked at the other viable medical properties of CBD. The paper itself suggests a wide range of possible therapeutic applications for various ailments that include Parkinson’s disease, Alzheimer’s disease, cerebral ischemia, diabetes, rheumatoid arthritis, various inflammatory diseases, nausea, and even cancer.

 

The paper is certainly an exciting and informative read on CBD, and it is accessible not only to medical professionals, but for anyone else who simply wants to read up on this amazing cannabinoid!

-Danny